Blue chips defy global headwinds as NZ reporting season exceeds forecasts
New Zealand’s blue-chip companies reported results that were generally better than expected despite elevated fuel prices, shipping disruption and supply-chain uncertainty, according to brokers and investors. Fisher & Paykel Healthcare raised revenue 14% to $2.31b and net profit 24% to $468.5m, lifting its dividend 22% to 52c. Mainfreight’s revenue rose 2% to $5.38b, profit fell 8.5% to $251m, but it said trading improved in April-May. Infratil surged on AI/data-centre exposure and forecast 2027
Strong earnings and dividend increase likely support NZX/ADR risk appetite for the medical devices name despite US tariff headwinds.
Fisher & Paykel Healthcare reported revenue +14% to $2.31B and net profit +24% to $468.5M, raising FY27 guidance and dividend.
Near-term bias upward on earnings/guidance credibility; upside depends on tariff pass-through and demand durability.
Background
The piece is a NZ reporting-season wrap arguing results exceeded forecasts amid elevated fuel prices, shipping disruption, and conflict-related uncertainty.
Why it matters
It highlights specific earnings/outlook upgrades and contract wins that can drive repricing in NZ large-cap equities, with particular emphasis on resilience and AI/data-centre exposure.
Market relevance
Concrete earnings/guidance and contract disclosures provide actionable catalysts for traders focused on NZ large caps and AI/data-centre infrastructure exposure.
Market effects
Broad ‘blue chip resilience’ narrative across healthcare, logistics, infrastructure/AI data centres, and dairy; supports risk-on positioning in NZ large caps despite fuel/shipping disruption.
NZ-specific read-through: export-driven firms and regions like Waikato cited as relatively stronger than Auckland/Wellington.
US tariff exposure (Fisher & Paykel) and Middle East conflict/fuel volatility (Mainfreight) connect NZ earnings sensitivity to global trade and energy conditions.
Alternative perspectives
The article notes the ‘full force’ of inflation/cost/pricing pressures may still be ahead, so today’s relief could fade if margins compress later.
Fuel volatility and supply-chain disruption are explicitly cited as ongoing risks; guidance durability beyond April–May (Mainfreight) and execution of large data-centre capex (Infratil) are key swing factors.
Key entities
- public companyFisher & Paykel Healthcare
Reported revenue/profit growth, raised FY27 guidance, and increased dividend despite US tariffs.
- public companyMainfreight
Reported results and said April–May trading stayed strong despite Middle East disruption and higher fuel prices.
- public companyInfratil
AI/data-centre exposure boosted by CDC’s large contract and Longroad Energy supply; provided FY27 earnings/capex guidance.
- public companyFonterra Shareholders’ Fund
Provided Q3 operating profit and lifted full-year earnings and milk payment forecast for 2026/27.
